March 28, 2024
mayank
Tata Nifty MidSmall Healthcare Index Fund details, Fund Portfolio, Fund Returns, Peer Comparison, Mutual Fund Guidance @chanakyamfguidance
Table of Contents:
- NFO Open date, Close date
- NFO Investment Strategy
- NFO Basic Details
- NFO Benchmark Index
- Past Performance of NFO Benchmark Index
- Performance Review of Fund Manager
- Should You Invest in this NFO?
- Invest Online
What is the Tata Nifty MidSmall Healthcare Index Fund Open Date, Close Date?
NFO opens on April 08, 2024
NFO will close on April 22, 2024
What is the Investment Strategy?
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
Basic Details
| Fund House | Tata Mutual Fund |
| Issue Open | 08 April 2024 |
| Issue Close | 22 April 2024 |
| Type | Open-ended |
| Category | Equity: Sectoral-Pharma |
| Min. Investment(Rs) | 5,000 |
| Plans | Growth, IDCW |
| Lock-in Period | NA |
| Exit Load | 0.25% for redemption Within 15 days |
| Riskometer | Very High |
| Benchmark | Nifty MidSmall Healthcare TRI |
What is the Benchmark Index of Tata Nifty MidSmall Healthcare Index Fund?
Nifty MidSmall Healthcare tracks the performance of the mid cap and small cap stocks within the healthcare sector. The index includes upto 30 stocks selected from the parent Nifty MidSmallcap 400 index based on the stock’s six-month average free-float market capitalization. The weight of each stock in the index is based on stock’s free float market capitalization.
Nifty MidSmall Healthcare Index can be used for a variety of purposes such as benchmarking fund portfolios, launching of index funds, ETFs and structured products.
Index Variant: Nifty MidSmall Healthcare Total Returns Index.
Past Performance of Benchmark Index
| Index Returns (%) | QTD | YTD | 1 Year | 5 Years | Since Inception |
| Price Return | 7.24 | 7.24 | 69.00 | 21.80 | 20.26 |
| Total Return | 7.35 | 7.35 | 69.87 | 22.72 | 21.43 |
| Statistics ## | 1 Year | 5 Years | Since Inception |
| Std. Deviation * | 12.25 | 16.06 | 18.32 |
| Beta (NIFTY 50) | 0.51 | 0.52 | 0.57 |
| Correlation (NIFTY 50) | 0.42 | 0.62 | 0.67 |
Fundamentals
| P/E | P/B | Dividend Yield |
| 47.04 | 5.42 | 0.5 |
Top constituents by weightage
| Company’s Name | Weight(%) |
| Max Healthcare Institute Ltd | 13.99 |
| Lupin Ltd. | 9.34 |
| Aurobindo Pharma Ltd. | 6.90 |
| Alkem Laboratories Ltd. | 6.15 |
| Fortis Healthcare Ltd. | 5.08 |
| Ipca Laboratories Ltd. | 3.83 |
| Laurus Labs Ltd. | 3.81 |
| Abbott India Ltd | 3.61 |
| Glenmark Pharmaceuticals Ltd | 3.30 |
| Syngene International Ltd. | 3.05 |
Performance Review of the Fund Manager of Tata Nifty MidSmall Healthcare Index?
1) Kapil Menon
Education: Mr. Menon has done B.Com
Experience: He has been working with Tata Mutual Fund since 2006.
Past Performance of his Schemes
Which Company Owns Tata Nifty MidSmall Healthcare Index Fund?
Tata Asset Management Private Ltd
Address: 9th Floor, Mafatlal Centre, Nariman Point, Mumbai – 400021
Website: http://www.tatamutualfund.com
Registrar & Transfer Agent:
Computer Age Management Services Ltd.
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai – 600002
Website: www.camsonline.com
Is it good to invest in Tata Nifty MidSmall Healthcare NFO?
Guidance for Tata Nifty MidSmall Healthcare Index Fund by Paresh Gordhandas, C.A., Research Analyst.
The Tata Nifty MidSmall Healthcare Index Fund is based on the Nifty MidSmall Healthcare Index. Nifty MidSmall Healthcare tracks the performance of the mid cap and small cap stocks within the healthcare sector. The index includes upto 30 stocks selected from the parent Nifty MidSmallcap 400 index. Hence, it is important to note that this index contains companies from the pharma and healthcare sector but only those falling within the mid and small cap category. So, the universe of companies is very small. And subsequently, the risk is higher. Big pharma companies like Cipla, Sun Pharma, Dr. Reddy’s do not form a part of this Index. Similarly, big hospital companies like Apollo Hospitals are also not included.
While pharma and healthcare as a sector is not that attractive in the current market scenario, investing in a sub-category of the same sector would mean more risk.
Can Avoid.
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
>> Chanakya’s Mutual Fund Guidance on YouTube
https://www.youtube.com/c/ChanakyaNiPothi
>> Join Chanakya MF’s Telegram Channel @
https://t.me/chanakyaMFGuidance
Quicklinks